(1.17%) 5 308.15 points
(0.88%) 39 908 points
(1.40%) 16 742 points
(1.04%) $78.83
(2.69%) $2.41
(1.41%) $2 393.10
(4.33%) $29.95
(2.83%) $1 074.20
(-0.60%) $0.919
(-1.17%) $10.67
(-0.75%) $0.788
(-0.62%) $90.75
Live Chart Being Loaded With Signals
Medesis Pharma S.A., a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs...
Stats | |
---|---|
Today's Volume | 7 697.00 |
Average Volume | 9 806.00 |
Market Cap | 5.80M |
EPS | €0 ( 2024-04-16 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -1.830 |
ATR14 | €0.0130 (1.11%) |
Medesis Pharma S.A. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Medesis Pharma S.A. Financials
Annual | 2022 |
Revenue: | €47 297.00 |
Gross Profit: | €-2.21M (-4 662.24 %) |
EPS: | €-0.630 |
FY | 2022 |
Revenue: | €47 297.00 |
Gross Profit: | €-2.21M (-4 662.24 %) |
EPS: | €-0.630 |
FY | 2021 |
Revenue: | €95 729.00 |
Gross Profit: | €79 024.00 (82.55 %) |
EPS: | €-0.606 |
FY | 2019 |
Revenue: | €230 000 |
Gross Profit: | €224 000 (97.39 %) |
EPS: | €-0.457 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Medesis Pharma S.A.
Medesis Pharma S.A., a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. Its products include NanoLithium (NP03), a clinical stage development product for the treatment of Alzheimer's disease; NanosiRNA DH for the treatment of Huntington's Disease; NU01 Plutonium and NU02 Cesium decorporation products for nuclear decorporation; a radioprotection drug to treat people irradiated following a civil or military nuclear accident (NP02 NanoManganese); NanosiRNA COVID-19, an antiviral treatment solution for viral diseases; and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for the treatment of oncology. The company was founded in 2003 and is based in Montpellier, France.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators